Sponsored by Consensus Cloud Solutions
March 01, 2023 – Health data exchange is essential to meaningful patient care. Providers must be able to leverage accurate and timely health information at the point of care to…
Anne Kim, Co-Founder and CEO of Secure AI Labs (SAIL)Clinical research is only as good and thorough as the data that’s available — and we need to do a better job of making that…
Continue Reading
Friedrich’s ataxia, an ultra-rare disease that causes progressively worsening muscle function that ultimately leads to death, now has its first FDA-approved therapy. The regulator has given the green light to a Reata Pharmaceuticals drug…
Continue Reading
The following is a guest article by Tamara Badza is a manager at Inviggo.
The Internet of Things (IoT) has transformed the healthcare industry, allowing for the collection and analysis of vast amounts of data…
What You Should Know:– Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery…
Continue Reading
Are you thinking of starting an online pharmacy delivery business? Here are 5 compelling reasons to help you decide!1. High-demand industry and high earning potential2. Low barrier to entry3. Constant profits once you set…
Continue Reading
By Mark Melchionna
February 28, 2023 – A recent survey from Pew Research Center found that although there are certain areas where patients see the benefits of artificial intelligence (AI) use in healthcare, the…
By Hannah Nelson
February 28, 2023 – Two new proposed rules from The Centers for Medicare & Medicaid Services (CMS) aim to advance health information exchange (HIE) interoperability and streamline prior authorization processes.
The proposed…
Researchers at the Harvard Wyss Institute are collaborating with a biotechnology company called Gameto to develop human ovarian organoids that will allow the study of reproductive and other health issues using tissues that closely…
Continue Reading
Aptinyx’s approach of treating neurological disorders by targeting a key receptor in the brain has fallen short again, this time in Parkinson’s disease. With its third clinical trial failure in less than a year,…
Continue Reading
